Botanical species · safety record

Lilium candidum

The EFSA Compendium of Botanicals holds 7 constituent measurements for Lilium candidum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lilium candidum L.

7Constituent measurements

0Safety records

5Cited sources

1Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Lilium candidum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Steroidal alkaloids	Bulb / clove	Solvent extraction	—	UV/VIS spectroscopy (photometry)	Resolve DOI
Steroidal furostan saponins	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Steroidal spirostane saponins	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Flowering top	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Alkaloids	Aerial part of plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Epoxides	Pollen-related	Solvent extraction	—	UV/VIS spectroscopy (photometry)	No resolvable identifier
Steroidal spirostane saponins	Flowering top	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Vachalkova, A., Eisenreichova, E., Haladova, M., Mucaji, P., Jozova, B., Novotny, L. Potential carcinogenic and inhibitory activity of compounds isolated from Lilium candidum L. . Neoplasma, 2000, vol. 47, no. 5, p. 313-318.
Mimaki, Y., Satou, T., Kuroda, M., Sashida, Y., Hatakeyama, Y. Steroidal saponins from the bulbs of Lilium candidum. PHYTOCHEMISTRY, 1999, vol. 51, no. 4, p. 567-573. DOI
Erdogan, I., Sener, B., Atta-ur-Rahman. Etioline, a steroidal alkaloid from Lilium candidum L.. BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2001, vol. 29, no. 5, p. 535-536. DOI
Haladova, Maria., Buckova, Anna., Eisenreichova, Eva., Tomko, Jozef., Uhrin, Dusan. Constituents of Lilium candidum L. acta facultatis pharmaceuticae universitatis comenianae, 1991, p. 151-174.
Toth, Gyula., Kajtar, Judit., Molnar, Peter., Szabolcs, Jozsef. The stereochemistry of natural 'cis-antheraxanthin'. Acta chimica academiae scientiarum hungaricae, 1978, p. 359-361.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature